STAT

Pelosi’s drug pricing plan would let Medicare negotiate prices for up to 250 drugs

The new legislation is more aggressive than prior concepts that had circulated among lobbyists and congressional staff this year.
Speaker Nancy Pelosi (D-Calif.)

WASHINGTON — House Speaker Nancy Pelosi unveiled her long-awaited plan to lower drug prices Thursday.

The progressive plan gives Democrats an aggressive counter to the White House’s numerous and widely covered efforts to lower drug prices. But the plan also serves, in some ways, as an olive branch to President Trump: Pelosi included many of the administration’s own ideas in her document, in apparent hopes of gaining his support.

According to a legislative summary obtained by STAT, the plan would enact an international price

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT1 min read
STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.

Related Books & Audiobooks